Pure Global AI
Applicant profile

Abiomed Inc.

Abiomed Inc.
Hong Kong MDACSUnited States2 registered devicesDec 03, 2021 – Aug 29, 2023
VerifiedMDD (Medical Device Division) · MDACS registry
2
Total devices
2
Risk classes
2021
First registration
2023
Most recent
Applicant overview
Applicant (EN)
Abiomed Inc.
Applicant (ZH)
Abiomed Inc.
Country
United States
美国
Address
22 Cherry Hill Drive, Danvers, Massachusetts 01923, USA
22 樱桃山大道, 丹弗斯, 马萨诸塞州 01923, 美国
Timeline
First registration
Dec 03, 2021
Most recent
Aug 29, 2023
Regulatory footprint
Search Abiomed Inc. across other regulatory registries
ThailandEuropean UnionColombiaSouth KoreaCanadaEcuador
Risk class breakdown
III1
IV1
Recent MDACS registrations
Latest 15 devices linked to this applicant
Circulatory Assist Units, Cardiac
循环辅助装置,心脏
Aug 29, 2023
Risk class
III
Authorised rep
DCH Auriga (Hong Kong) Limited奥利佳(香港)有限公司
Catheters, Cardiac
导管,心脏
Dec 03, 2021
Risk class
IV
Authorised rep
DCH Auriga (Hong Kong) Limited奥利佳(香港)有限公司
About this profile

Abiomed Inc. is associated with 2 medical devices registered under the Hong Kong Medical Device Administrative Control System (MDACS). Explore bilingual product names, risk classes, authorised representatives, and life-cycle milestones.